PRESS RELEASE published on 06/17/2024 at 07:00, 1 year 10 months ago Inside Information / Other news releases Innate Pharma shares updated results from the Sanofi developed blood cancer Phase 1/2 SAR443579/IPH6101 trial, showing promising clinical efficacy and safety in patients with R/R AML Sanofi Innate Pharma Blood Cancer NK Cell Engager Phase 1/2 Trial
BRIEF published on 05/28/2024 at 07:05, 1 year 10 months ago Innate Pharma announces its participation in upcoming investor conferences Biotechnology Investor Conferences Immunotherapy Health Innate Pharma
BRIEF published on 05/23/2024 at 22:05, 1 year 11 months ago Results of the Combined General Meeting of Innate Pharma Voting Results Supervisory Board General Assembly Innate Pharma
PRESS RELEASE published on 05/23/2024 at 22:00, 1 year 11 months ago Inside Information / Other news releases Innate Pharma announces the voting results of its 2024 AGM. Quorum at 44.92%. Re-election of two Supervisory Board members. Details available on company's website Voting Results Supervisory Board Quorum 2024 AGM Innate Pharma
BRIEF published on 05/21/2024 at 07:05, 1 year 11 months ago Clarification on the status of SAR443579 treatment by Innate Pharma FDA Sanofi Innate Pharma SAR443579 Fast Track
Published on 04/25/2026 at 03:10, 1 day 23 hours ago BEACN Announces Financial Results for Year Ended December 31, 2025
Published on 04/24/2026 at 22:05, 2 days 4 hours ago Critical Elements Mourns the Loss of Director Marc Simpson
Published on 04/24/2026 at 22:00, 2 days 4 hours ago Kidoz Inc. to Present 2025 Results and Highlight Platform Expansion and Business Momentum
Published on 04/24/2026 at 15:00, 2 days 11 hours ago Norsemont Reports Significant Copper, Lead & Zinc Values in Three Choquelimpie Drill Holes
Published on 04/24/2026 at 15:00, 2 days 11 hours ago First Canadian Graphite Appoints Scott Kelly As Chief Financial Officer
Published on 04/27/2026 at 01:05, 1 hour 15 minutes ago GLN Connects to Vietnam's National QR Network, Enabling Nationwide QR Payments
Published on 04/26/2026 at 21:15, 5 hours 5 minutes ago Changan Group Unveils Updated "Vast Ocean Plan 2.0" and Highlight Next-Generation BlueCore Hybrid at Auto China 2026
Published on 04/26/2026 at 20:15, 6 hours 5 minutes ago Safety. For Family: TIGGO9 Completes Public Three-Vehicle Composite Crash Verification During the 2026 International Business Summit
Published on 04/26/2026 at 10:20, 16 hours ago EQS-Adhoc: Vitruvia Medical AG: Annual Results as of December 31, 2025
Published on 04/26/2026 at 09:05, 17 hours 15 minutes ago Natural Expressions Unveils Performance 7: The Era of "Drop-and-Mow" Wireless Robotic Mowing Arrives in Europe
Published on 04/24/2026 at 17:45, 2 days 8 hours ago Imerys-04-2026-information-share-capital-and-voting-rights-as-of-31-March-2026
Published on 04/24/2026 at 16:37, 2 days 9 hours ago Availability of the 2025 Universal Registration Document (URD)
Published on 04/23/2026 at 19:27, 3 days 6 hours ago Annual Shareholders' Meeting 2026 - Conditions of availability of the preparatory documents
Published on 04/23/2026 at 18:18, 3 days 8 hours ago Aéroports de Paris SA - Sale by Groupe ADP of securities representing 3.4% with option to sell an additional 3.9% of GAL's equity share capital to GMR Group
